US: FDA backs Pfizer COVID-19 boosters for seniors, high-risk

US: FDA backs Pfizer COVID-19 boosters for seniors, high-risk

[ad_1] The US moved a step nearer Wednesday to providing booster doses of ‘s COVID-19 vaccine to senior residents and others at excessive danger from the virus because the Meals and Drug Administration signed off on the focused use of additional pictures. The FDA licensed booster doses for Individuals who’re 65 and older, youthful adults … Read more